<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01460797</url>
  </required_header>
  <id_info>
    <org_study_id>Glycemic index and Metformin</org_study_id>
    <nct_id>NCT01460797</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of a Caloric Restriction High/Low Glycemic Index Diet Plus Metformin in Overweight/Obese Subjects</brief_title>
  <official_title>Effects of a Caloric Restriction High/Low-glycemic Index Diets and in Combination With Metformin on Glucose Metabolism, Lipid Profile and Body Composition in Overweight/Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Caio Eduardo Gonçalves Reis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Brasilia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fund to support research of the Federal District, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Brasilia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of obesity and Type 2 diabetes has increased dramatically worldwide. Research
      on Glycemic Index (GI) diets has been largely developed, however the combination with
      metformin in humans was not investigated yet. We hypothesized that the low-GI diet in
      combination with metformin would elicit greater improvements on glucose metabolism, lipid
      profile and body composition on overweight or obese type 1 subjects. This study aims to
      evaluate the metabolic effects of the adoption of dietary advice to follow caloric
      restriction high/low GI diets, and low-GI diet associated with metformin on glucose
      metabolism, lipid profile and body composition on overweight or obese type 1 subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All groups (Low/High-GI and Low-GI + Metformin) showed significant reduction in
      anthropometric parameters, but only Low-GI and Low-GI + Metformin groups have an improvement
      in body composition parameters. In addition, the Low-GI group achieved better results in
      metabolism of carbohydrates (glucose, insulin, Cederholm Index, and HOMA-β) and lipids (Chol,
      TAG, LDL-C, VLDL-C, and TC/HDL-c). These results show the benefits of Low-GI diet on
      metabolic parameters in overweight or obese type 1 subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <primary_completion_date type="Actual">June 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose Metabolism</measure>
    <time_frame>0 and 4 months</time_frame>
    <description>2-hour oral glucose tolerance test (Glucose and Insulin levels), glucose and insulin IAUC, HbA1c, HOMA-IR, HOMA-β, and Cederholm Index.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipid Profile</measure>
    <time_frame>0 and 4 months</time_frame>
    <description>Cholesterol, TAG, LDL-C, VLDL-C, HDL-c, and Cholesterol/HDL-c ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition</measure>
    <time_frame>0 and 4 months</time_frame>
    <description>Body weight, Height, Body mass index, Body fat mass, Free fat body mass, Waist circumference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Assessment</measure>
    <time_frame>0 and 4 months</time_frame>
    <description>FSH hormone, urea, creatinine, and uric acid urinary levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food Intake</measure>
    <time_frame>0 and 4 months</time_frame>
    <description>Energy intake, macronutrients and fiber consumption</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>High Glycemic Index</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hypocaloric diet with predominating high glycemic index foods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Glycemic Index</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hypocaloric diet with predominant low glycemic index foods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Glycemic Index plus Metformin</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hypocaloric diet with predominant low glycemic index foods plus Metformin (1g/d)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glycemic Index Diets and Metformin hydrochloride</intervention_name>
    <description>1g of Metformin hydrochloride a day in High Glycemic Index Diet</description>
    <arm_group_label>High Glycemic Index</arm_group_label>
    <arm_group_label>Low Glycemic Index</arm_group_label>
    <arm_group_label>Low Glycemic Index plus Metformin</arm_group_label>
    <other_name>High Glycemic Index</other_name>
    <other_name>Low Glycemic Index</other_name>
    <other_name>High Glycemic Index plus Metformin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants were adults (18-50 y), with body mass index (BMI) between 25-35 kg/m².

          -  Subjects with adequate glycemic and insulinemic response after oral glucose tolerance
             test: Hypocaloric diet with predominating high glycemic index foods;

          -  Subjects with altered glycemic response presented at the 120 min point either glycemia
             &lt;140mg/dL and insulin level &gt;40 µUI/ml: Hypocaloric diet with predominant low glycemic
             index foods;

          -  Subjects with impaired glucose tolerance presented at the 120 min point glycemia 140 -
             199mg/dL and insulin &gt;40 µUI/ml: Hypocaloric diet with predominant low glycemic index
             foods and metformin.

        Exclusion Criteria:

          -  Smokers

          -  Pregnant or lactating

          -  Diagnosis of any metabolic diseases

          -  Were under medication and therapeutic diet, except oral contraceptive for women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa HM da Costa, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Brasília</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Health Sciences, University of Brasília</name>
      <address>
        <city>Brasília</city>
        <state>DF</state>
        <zip>70910-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2011</study_first_submitted>
  <study_first_submitted_qc>October 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2011</study_first_posted>
  <last_update_submitted>October 25, 2011</last_update_submitted>
  <last_update_submitted_qc>October 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Brasilia</investigator_affiliation>
    <investigator_full_name>Caio Eduardo Gonçalves Reis</investigator_full_name>
    <investigator_title>Sub-Investigator</investigator_title>
  </responsible_party>
  <keyword>Glycemic index</keyword>
  <keyword>Caloric restriction</keyword>
  <keyword>Energy intake</keyword>
  <keyword>Glucose</keyword>
  <keyword>Lipid Metabolism</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>HDL Cholesterol</keyword>
  <keyword>LDL Cholesterol</keyword>
  <keyword>Obesity</keyword>
  <keyword>Metformin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

